
Journal of Molecular Structure p. 134 - 140 (2006)
Update date:2022-08-24
Topics:
Roussel, Pascal
Bentiss, Fouad
Drache, Michel
Conflant, Pierre
Lagrenee, Michel
Wignacourt, Jean-Pierre
A crystalline form of anhydrous 3,5-pyrazole dicarboxylic acid (H3pdc), H3pdc-α, which is the most stable form at room temperature, has been identified by a variable temperature diffraction study of the commercial form, H3pdc,H2O. Single crystals of H3pdc,H2O, anhydrous H3pdc-β, the high temperature form, as well as Ni(Hpdc),4H2O and Ba(H2pdc)2(H3pdc)2 have been prepared, and their crystal structures determined. The structures of H3pdc,H2O, and H3pdc-β consist of a planar central pyrazole ring, with two carboxylic groups slightly twisted from coplanarity, due to a complex hydrogen bonding scheme. The α form transforms into the β variety upon heating (>240 °C). The mononuclear complex, Ni(Hpdc),4H2O, in which deprotonated H3pdc serves as a bidentate ligand, has been characterized. The crystal structure of Ba(H2pdc)2(H3pdc)2 displays a 50% cationic partial occupancy, with double layers of [Ba0.5(H2pdc)(H3pdc)]∞ planar, polymeric type ribbons along the [010] direction, linked to each other via the Ba coordination scheme along the a axis of the unit cell, with a stacking of Ba(H2pdc)2(H3pdc)2 layers parallel to (001).
Shanghai Balmxy Pharmaceutical Co., Ltd
Contact:0086-21-24206007
Address:Room 402, 15#, No. 909 wangyue Road, shanghai, P. R. China
Anhui Gusheng Import&Export CO.,LTD
Contact:86-551-63662296
Address:Jinzhai Road NO.162 ,hefei, china
Kaiping Genuine Biochemical Pharmaceutical Co.,Ltd.
Contact:+86-750-2881198
Address:No.1, Xinke Road, Shatang Town, Kaiping, Guangdong Province, P.R.China
Anyang Double Circle Auxiliary CO.,LTD
Contact:0086-134 6082 4403
Address:dongfeng road, anyang city, henan province,china
Rudong Zhenfeng Yiyang Chemical Co., Ltd.
Contact:0513-84573047
Address:South Fengli Town, Rudong County, Jiangsu Province, China
Doi:10.1039/c5cc00211g
(2015)Doi:10.1107/S0108270105005500
(2005)Doi:10.1021/acs.joc.6b02522
(2016)Doi:10.1246/cl.2001.368
(2001)Doi:10.1016/j.farmac.2003.07.003
(2003)Doi:10.1016/j.saa.2012.09.071
(2013)